PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Estradiol - Vaginal atrophy
PAD Profile : Estradiol - Vaginal atrophy
Keywords :
vaginal dryness, vaginal oestrogen, oestrogen deficiency, post menopausal symptoms, hormone replacement therapy, HRT, menopause, estradiol vaginal tablets, estradiol pessaries, atrophic vaginitis, oestradiol pessaries
Brand Names Include :
Vagirux, Vagifem, Gina, Estring
Traffic Light Status
Status 1 of 2.
Status :
Green
Important
Formulations :
- Vaginal tablets
Important Information :
Prescribe 10mcg vaginal tablets generically
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
APC August 2023 agreed to the generic prescribing of estradiol 10mcg vaginal tablets.
Patients receiving the brands (Vagirux, Vagifem, Gina) can be switched to a generic prescription.
Documents :
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
03 July 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands APC has agreed a traffic light status and place in therapy for the treatments of menopausal disorders in line with the CKS recommenations:
Associated BNF Codes
07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.02.01. Preparations for vaginal and vulval changes